American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Berger
    Berger
  7. Baselga
    Baselga
  8. Reis-Filho
    Reis-Filho
  9. Cordon-Cardo
    Cordon-Cardo
  10. Schultz
    Schultz

Groups

  1. Department of Medicine (2074)
  2. Solid Tumor Oncology Division (1737)
  3. GSK Faculty (1623)
  4. Sloan Kettering Institute Faculty (794)
  5. Sloan Kettering Institute Postdocs (766)
  6. Department of Pathology and Laboratory Medicine (715)
  7. Human Oncology and Pathogenesis Program (677)
  8. Surgery (639)
  9. Breast Medicine Service (605)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (570)
Search Within
Formats
  1. Meeting Abstract (1996)
  2. Journal Article (1966)
  3. Editorial (41)
  4. Review (22)
  5. Conference Paper (14)
  6. Correspondence (4)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2074)
  2. Solid Tumor Oncology Division (1737)
  3. GSK Faculty (1623)
  4. Sloan Kettering Institute Faculty (794)
  5. Sloan Kettering Institute Postdocs (766)
  6. Department of Pathology and Laboratory Medicine (715)

More Groups

People
  1. David Solit (174)
  2. Marc Ladanyi (157)
  3. Neal Rosen (141)
  4. Clifford Hudis (140)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (6)
  2. 2024 (55)
  3. 2023 (63)
  4. 2022 (261)
  5. 2021 (233)
  6. 2020 (271)

More Years

Publications
  1. Cancer Research (2685)
  2. Clinical Cancer Research (1363)

Results (4048)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combination of cyclophosphamide chemotherapy with immune modulation overcomes resistance to checkpoint blockade in a pre-clinical melanoma model
    Meeting Abstract

    Betof Warner, A.; Hirschhorn, D.; Mangarin, L. M.; Hamadene, L.; Cohen, A. D.; Rizzuto, G. A.; Wolchok, J. D.; Merghoub, T.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Genome-scale CRISPR screen finds prostate lineage specific dependencies
    Meeting Abstract

    Attari, A.; Misek, S.; Eser, P.; Yeagley, A.; Chen, Y.; Boehm, J.; Tseng, Y. Y.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Tumour spatial heterogeneity in breast cancer and the impact on clinical management
    Meeting Abstract

    Bayani, J.; Trinh, Q. M.; Quintayo, M. A.; Crozier, C.; Hopkins, M.; Qiao, J.; Cheung, A.; Mainprize, J.; Morris, Q.; Spears, M.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Preclinical activity of seribantumab in gastrointestinal cancers with NRG1 fusions
    Meeting Abstract

    Odintsov, I.; Lui, A. J.; Bloom, P. R.; Vojnic, M.; Leland, S.; Ladanyi, M.; Somwar, R.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Evolution of OncoKB, a precision oncology knowledgebase
    Meeting Abstract

    Suehnholz, S. P.; Kundra, R.; Zhang, H.; Smith, S.; Nissan, M.; Yao, Y.; LaFave, L.; Gala, K.; Miles, L.; Arcila, M. E.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Emergence of a hyper-proliferative phenotype in TET2 edited human CAR T cells
    Meeting Abstract

    Jain, N.; Zhao, Z.; Iyer, A.; Lopez, M.; Feucht, J.; Koche, R.; Yang, J.; Zhan, Y.; Sadelain, M.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Genomic and molecular features of metachronous metastasis in clear cell renal cell carcinoma
    Meeting Abstract

    Mojtabavi Naeini, M.; Rohatgi, N.; Ghoshdastider, U.; Hakimi, A. A.; Skanderup, A. J.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • The HER2xHER3 bi-specific antibody Zenocutuzumab is effective at blocking growth of tumors driven by NRG1 gene fusions
    Meeting Abstract

    Odintsov, I.; Khodos, I.; Espinosa-Cotton, M.; Lui, A. J.; Mattar, M.; Schram, A. M.; Schackmann, R. C.; Lammerts van Bueren, J.; Geuijen, C. A.; de Stanchina, E.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Mechanosurveillance by immunity targets mechanical compliance of metastatic cells
    Meeting Abstract

    Tello-Lafoz, M.; Srpan, K.; Hu, J.; Romin, Y.; Calo, A.; Hsu, K. C.; Massagué, J.; Huse, M.; Er, E. E.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • MAPK pathway activation represents a therapeutic vulnerability in ASCL1-driven SCLC
    Meeting Abstract

    Caeser, R.; Hulton, C.; Durani, V.; Costa, E.; Little, M.; Shah, N. S.; de Stanchina, E.; Poirier, J. T.; Rudin, C. M.; Sen, T.
    Cancer Research (2021)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: